Web Search Site Search HCV Patient Assistance Programs (click here for details)   Merck Zepatier Patient Assistance Program (click here for details)   Abbvie G/P, Mavyret Patient Support (click here for details)   Gilead Hepatitis C Patient Assistance Program - Epclusa, Vosevi, Harvoni, Sovaldi (sofosbuvir) (click here for details)   Ryan White Care Act Hepatitis C & B Language (click here for details)   HCV Copayment Assistance - HealthWell Foundation (click here for details)   Current HIV Articles and News Updates     HIV     NIH: Is marijuana addictive? - Yes, You Can Become Addicted to Marijuana. And the Problem is Growing. - (06/15/18)   ViiV Healthcare reports positive results for landmark phase III studies for dolutegravir and lamivudine - (06/15/18)   Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study - (06/13/18)   Older MACS Men - Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV - (06/12/18)   (MACS) Long-term kidney function, proteinuria, and associated risks among HIV-infected and uninfected men - (06/12/18)   Travel Scholarships Available for the 2018 HIV Co-morbidity Workshop - NYC Oct 13-14 - (06/12/18)   ASM - Primary Efficacy Results of PRO 140 SC in a Pivotal Phase 2b/3 Study in Heavily Treatment-Experienced HIV-1 Patients - Mark Mascolini - (06/11/18)   HIV-1 resistance rarely observed in subjects using darunavir once-daily regimens across clinical studies - (06/11/18)   Loneliness in Older Adults Living with HIV (58%) - (06/7/18)   TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy - (06/4/18)   Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer - TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy - (06/4/18)   Pharm: Population pharmacokinetic analysis for darunavir and tenofovir alafenamide in HIV-1-infected patients on the darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen (AMBER and EMERALD studies) - (06/4/18)   Pharm: SIMULATED PHARMACOKINETIC INTERACTIONS OF RIFAMPICIN WITH RITONAVIR-BOOSTED DARUNAVIR - (06/4/18)   Pharm: Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202 - (06/4/18)   More HIV Articles...         News Updates     NY Community Pharmacy on the Frontlines in the Fight Against HIV - Provides PEP - (05/15/18)   SAMHSA Head Stands Firm on Marijuana's Dangers - (05/09/18)   ViiV Healthcare gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe - (03/29/18)   More News Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     EASL: Summary from EASL 2018 for Hepatitis C (HCV) HCV in 2018: Success stories and remaining challenges? - Prof. Dr. J.K. Rockstroh Department of Medicine I University of Bonn Sigmund-Freud-Str. 25 53105 Bonn Germany- (05/04/18)   EASL: Summary from EASL 2017 for Hepatitis C - Global implementation of Hepatitis C (HCV) treatment: What are the successes, what are the remaining challenges? - Jurgen K. Rockstroh M.D., Professor of Medicine University of Bonn, Germany - (06/01/17)   CROI: Summary from CROI 2017 for viral Hepatitis HCV - elimination on its way: dream or emerging reality? - Jurgen K. Rockstroh M.D., Professor of Medicine University of Bonn, Germany   AASLD: Summary from AASLD 2017 for Hepatitis C HCV: Game over? - Jurgen K. Rockstroh M.D., Professor of Medicine Department of Medicine I, University Hospital Bonn, Bonn, Germany -   DDW: Emergence and Long-term Persistence of NS3, NS5A, and NS5B Resistance Associated Substitutions After Treatment With Direct-acting Antivirals - (06/01/18)   DDW: Long-Term Follow-up of Patients with Chronic HCV and F2-F3 Fibrosis After Achieving SVR with DAA-Based Therapy: Results from the Gilead SVR Registry - (06/01/18)   Nonalcoholic fatty liver disease, metabolic syndrome, and the fight that will define clinical practice for a generation of hepatologists - (06/15/18)   Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients - (06/12/18)   HCV 99.7% SVR-Cure Rates in GT1a - (06/09/18)   We know DAAs work for PWID, now what? Simplifying HCV testing, linkage to care and treatment - (06/09/18)   Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus - (06/09/18)   Achieving hepatitis C elimination in Europe - To treatment scale-up and beyond - (06/09/18)   More Hep C Articles...         Hepatitis B     Nucleic acid polymers: much-needed hope for hepatitis D? - Comment - (05/21/18)   Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial - (05/21/18)   EASL: Updated follow-up analysis in the REP 401 protocol: treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2a - (05/21/18)   EASL: Establishment of persistent functional remission of HBV and HDV infection following REP 2139-Ca and pegylated interferon alpha-2a therapy in patients with chronic HBV / HDV co-infection: 1.5 -2 year follow-up results from the REP 301-LTF study - (05/21/18)   More Hep B Articles...   Check Out Our Special NATAP Features   Link to conference listings 2018 Conferences - key HIV & Hepatitis related meetings   not necessarily listed here in order of date being held.   International Paris Hepatology Conference 2018 https://www.aphc.info/   HIV & Women 2018 - International Workshop on HIV & Women March 2-3 2018 in Boston MA at the Colonnade Hotel, just prior to CROI   http://www.virology-education.com/event/upcoming/international-workshop-hiv-women/   http://www.croiconference.org/   http://www.apasl2018.in/   http://www.bhiva.org/BestofCROI2018.aspx   16th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD) in Toronto Canada June 14th - 17th 2018   http://www.globalhepatitissummit2018.com/   http://www.acthiv.org/agenda2018.asp   Annual Meeting Paris 11-15 April 2108 https://ilc-congress.eu/   https://isnv.org/   https://www.aan.com/conferences-community/annual-meeting/   https://hivhepamericas.org/   Co-infection Workshop 2018 14th International Workshop on Co-infection: HIV, Hepatitis and Liver Disease   16 - 18 May 2018 in Seville, Spain   http://www.virology-education.com/event/upcoming/14th-co-infection-workshop-2018/   Antiviral PK Workshop 2018   International Workshop on Clinical Pharmacology of Antiviral Therapy 2018 22-24 May, in Washington DC, USA   Formally known as the International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy http://www.virology-education.com/event/upcoming/antiviralpk-workshop-2018/   16th European Meeting on HIV & Hepatitis 2018   European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance 30 May - 1 June 2018 at the Roma Eventi - Fontana di Trevi Conference Centre in Rome, Italy   http://www.virology-education.com/event/upcoming/16th-european-hiv-hepatitis-workshop-2018/   http://ddwmeeting.com/   7th Asian Conference of Hepatitis and AIDS (ACHA)   9 and 10 June 2018 and Beijing China   ACHA 2018 http://www.virology-education.com/event/upcoming/acha-2018/   https://www.hiv-clinical-forum.org/   http://asm-microbe2018.org/   Spanish HIV Clinical Forum: Integrase Inhibitors 8-9 June, 2018   The HIV CLINICAL FORUM is an abstract-driven educational program dedicated to the integration of science and clinical practice focusing on integrase inhibitors. This state-of-the-art scientific program offers plenary lectures followed by ample time for Q&A and debate, stimulating interaction in order to bridge the knowledge gap between experts and the HIV treating community in Spain. The program will also include clinical case presentations to discuss real life challenges. Website: Spanish HIV Clinical Forum 2018   http://www.hiv-clinical-forum.org/   10th Workshop on HIV Pediatrics   International Workshop on HIV Pediatrics 2018 Scheduled on 20 and 21 July 2018, Amsterdam, the Netherlands   http://www.virology-education.com/event/upcoming/10th-workshop-hiv-pediatrics/   Towards and HIV Cure: Community Engagement Workshop   21 July 2018 Amsterdam, then Netherlands https://www.iasociety.org/HIV-Programmes/Programmes/Towards-an-HIV-Cure/Events/Towards-an-HIV-Cure-Community-Engagement-Workshop-2018 Sept 6-9 2018 Hyatt Regency Orlando http://2018usca.org/   http://www.aids2018.org/   7th International Symposium on Hepatitis Care in Substance Users 19 - 21 September 2018, Cascais, Portugal.   www.inhsu2018.com   http://www.hivhealthyliving.com/?utm_campaign=website&utm_medium=email&utm_source=sendgrid.com   http://www.hivhealthyliving.com/?utm_campaign=website&utm_medium=email&utm_source=sendgrid.com   http://www.idweek.org/   4th Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV   11-12 October 2018 in Prague, Czech Republic   http://www.virology-education.com/event/upcoming/4th-central-eastern-european-meeting-viral-hepatitis-co-infection-hiv/   https://www.intmedpress.com/comorbidities/   http://www.hivr4p.org/   http://hivglasgow.org/   https://www.aasld.org/events-professional-development/liver-meeting http://www.virology-education.com/event/upcoming/hiv-dart-emerging-viruses-2018/   International HBV Cure Workshop 2018 Toronto Canada 7 November 2018 5th International HBV Cure Workshop 2018, which will take place on 7 November 2018 in Toronto, Canada   http://www.virology-education.com/event/upcoming/hbv-cure-workshop-2018/   http://www.hivresistance2017.co.za/ Digestive Disease Week 02nd - 05th June 2018 Washington, D.C   19th International Workshop on Clinical Pharmacology of Antiviral Therapy May 22, 2018 Baltimore, USA | Baltimore Marriott Inner Harbor   EASL - European Association for the Study of the Liver Paris France 11-15 April 2018   EASL - European Association for the Study of the Liver Paris France 11-15 April 2018   APASL - 27th Annual Conference of the Asian Pacific Association for The Study of the Liver March 14-18 2018 Aerocity. New Delhi   Conference on Retroviruses and Opportunistic Infections (CROI) March 4 to March 7, 2018, Boston MA   19th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV - Milan, Italy Oct 23-25 2017   EACS - 16th European AIDS Conference October 25-27 2017 Milan, Italy   American Association for the Study of Liver Diseases AASLD Washington DC October 2017   ID Week San Diego CA October 4-8, 2017 New York   8th International Workshop on HIV and Aging October 2-3, 2017 New York   IAS 2017: Conference on HIV Pathogenesis Treatment and Prevention Paris, France July 23-26 2017   18th International Workshop on Clinical Pharmacology of Antiviral Therapy June 14-17, 2017 Chicago, Ill.   The International Liver Congress™ EASL 2017 - European Association for the Study of the Liver Amsterdam, The Netherlands. 2017   26th Conference of the Asian Pacific Association for the Study of the Liver 2017 APASL, Feb 15-19 Shanghai, China   CROI 2017 - Conference on Retroviruses and Opportunistic Infections (CROI) February 13-16, 2017, Seattle WA   AASLD The Liver Meeting Boston MA November 2016   IDWeek 2016, October 26-30, 2016, New Orleans   HIV Glasgow 23-26 October 2016 Glasgow, UK   HIV Research for Prevention (HIVR4P) October 17-19, 2016 Chicago   7th International Workshop on HIV and Aging September 26-27, 2016 Washington, DC   Paris Special EASL Meeting Pais, France September 23-24, 2016   18th International Workshop on Comorbidities and Adverse Drug Reactions in HIV, September 12-13, 2016, New York   International AIDS Conference Durban, South Africa July 18-22, 2016   ASM/ICAAC June 16-20 2016 Boston MA   17th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy June 8-10, 2016, Washington DC   DDW - Digestive Disease Week 2016 San Diego, CA May 16-19, 2016   The International Liver Congress™ EASL - European Association for the Study of the Liver Barcelona, Spain 13-17 April 2016   Conference on Retroviruses and Opportunistic Infections (CROI) February 22-25, 2016, Boston MA   APASL 25th Conference of the Asian Pacific Association for the Study of the Liver Feb 20-24 2016, Tokyo, Japan   HEPDART 2015: Frontiers in Drug Development for Viral Hepatitis December 6-10 2015 Wailea, HI   66th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 13-17 2015   (IWCADRH) 17th Intl Workshop on Comorbidities and Adverse Drug Reactions in HIV Oct 20-22 2015, Barcelona, Spain   15th European AIDS Conference (EACS) October 21-24, 2015 Barcelona   IDSA/IDWeek October 7-11 2015 San Diego   6th International Workshop on HIV and Aging October 5-6, 2015 Washington, DC   ICAAC 2015 55th Interscience Conference on Antimicrobial Agents and Chemotherapy September 5-9, 2015, San Diego, CA   IAS 2015: 8th IAS Conference on HIV Pathogenesis Treatment and Prevention Vancouver Canada 18-22 July 2015   16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 26-28, 2015 Washington, DC   DDW - Digestive Disease Week 2015 May 16-19, 2015 Washington DC United States   EASL - The International Liver Congress 2015 50th Annual Meeting of the European Association for the Study of the Liver Vienna, Austria April 22-26   The 24th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2015) Istanbul, Turkey, March 12-15, 2015   22nd Conference on Retroviruses and Opportunistic Infections Seattle Washington Feb 23 - 26, 2015   65th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 7-11 2014   HIV Drug Therapy Glasgow November 2-6, 2014 Glasgow, UK   5th International Workshop on HIV and Aging. October 21-22, 2014 Baltimore   ACG Annual Scientific Meeting Philadelphia, PA, October 20, 2014   16th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV Philadelphia USA Oct 6-8, 2014   ID Week Oct 8-12 2014 Philadelphia   AASLD/EASL Special Conference on Hepatitis C New York City, New York September 12 - 13   ICAAC 2014 54th Interscience Conference on Antimicrobial Agents and Chemotherapy September 5-9, 2014 Washington, DC   20th International AIDS Conference July 20-25, 2014 Melbourne, Australia   International Workshop on Antiviral Drug Resistance June 3-7 2014, Berlin, Germany   15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 19- 21, 2014, Washington, DC   DDW - Digestive Disease Week 2014 May 4, 2014, Chicago Illinois, United States   EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom April 9-13   (APASL) 24th Conference of the Asian Pacific Association for the Study of the Liver Brisbane, Australia 12-15 March, 2014   21st Conference on Retroviruses and Opportunistic Infections Boston MA March 3 - 6, 2014   6th HIV Persistence during Therapy - Sixth International Workshop Miami, Dec 3-6, 2013   Fourth International Workshop on HIV and Women January 13-14, 2014 Washington DC   HEPDART 2013: Frontiers in Drug Development for Viral Hepatitis December 8-12, 2013 Big Island, Hawaii   64rd Annual Meeting of the American Association for the Study of Liver Diseases Washington, DC Nov 1-5 2013   4th International Workshop on HIV and Aging October 30-31, 2013 Baltimore, MD   View More Conference Reports...   Coming of AGE. A guide to ageing well with HIV - 06/15/11 La informacion Que Necesitas Sobre el VIH - 06/15/10 New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Support Provided by: Abbvie, Genentech, Gilead, Janssen Therapeutics, Merck, Roche, & ViiV   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.   New Pegasys Patient Assistance Program   has generous provisions for patients who want to start HCV therapy with Pegasys and are uninsured. Since Roche & Genentech merged the Genentech Access Solutions P rogram took over this program starting Sept 1 2010 and as I say it is a generous transparent program.   http://www.pegasysaccesssolutions.com   866 422-2377